Pages that link to "Q26782621"
Jump to navigation
Jump to search
The following pages link to Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research (Q26782621):
Displaying 50 items.
- Atypical Femur Fractures in Patients Treated with Bisphosphonates: Identification, Management, and Prevention (Q28079133) (← links)
- Osteoporosis: advances in risk assessment and management (Q30240073) (← links)
- Observations following discontinuation of long-term denosumab therapy. (Q33563846) (← links)
- UK clinical guideline for the prevention and treatment of osteoporosis (Q33581078) (← links)
- Recent advances in the management of osteoporosis (Q33672136) (← links)
- Osteoporosis: a discussion on the past 5 years (Q33700265) (← links)
- Antiresorptive effect of a cathepsin K inhibitor ONO-5334 and its relationship to BMD increase in a phase II trial for postmenopausal osteoporosis (Q33814283) (← links)
- Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data (Q36378748) (← links)
- Study of Adverse Effect Profile of Parenteral Zoledronic Acid in Female Patients with Osteoporosis (Q36541909) (← links)
- Differences in the trajectory of bone mineral density change measured at the total hip and femoral neck between men and women following hip fracture (Q37172294) (← links)
- Reprint of: The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide (Q38402233) (← links)
- The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide (Q38406462) (← links)
- Investigational anabolic agents for the treatment of osteoporosis: an update on recent developments (Q38610545) (← links)
- Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density (Q38648319) (← links)
- The Efficacy of Low-intensity Vibration to Improve Bone Health in Patients with End-stage Renal Disease Is Highly Dependent on Compliance and Muscle Response (Q38666440) (← links)
- Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned (Q38666521) (← links)
- Safety issues and adverse reactions with osteoporosis management (Q38677822) (← links)
- Management of bone mineral density in HIV-infected patients (Q38711437) (← links)
- Current Controversies in the Management of Myeloma Bone Disease (Q38748577) (← links)
- Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis. (Q38793382) (← links)
- Osteoporosis: Treat-to-Target (Q38943051) (← links)
- Review: Breaking From Bisphosphonates (Q38992765) (← links)
- Addressing the Crisis in the Treatment of Osteoporosis: A Path Forward (Q39014377) (← links)
- Own the Bone, a System-Based Intervention, Improves Osteoporosis Care After Fragility Fractures. (Q39077620) (← links)
- Use of bone turnover markers in postmenopausal osteoporosis. (Q39423898) (← links)
- Osteoporosis treatment: recent developments and ongoing challenges (Q39423904) (← links)
- Stiffness and strength of bone in osteoporotic patients treated with varying durations of oral bisphosphonates (Q39569410) (← links)
- Rheumatoid Arthritis Exacerbates the Severity of Osteonecrosis of the Jaws (ONJ) in Mice. A Randomized, Prospective, Controlled Animal Study (Q39942547) (← links)
- Atypical fracture with long-term bisphosphonate therapy is associated with altered cortical composition and reduced fracture resistance. (Q41477033) (← links)
- Promotion effect of extracts from plastrum testudinis on alendronate against glucocorticoid-induced osteoporosis in rat spine (Q41631385) (← links)
- Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis. (Q41928631) (← links)
- Difference in the trajectory of change in bone geometry as measured by hip structural analysis in the narrow neck, intertrochanteric region, and femoral shaft between men and women following hip fracture (Q42682902) (← links)
- Osteoporosis treatment: bisphosphonates reign to continue for a few more years, at least? (Q43573918) (← links)
- Osteoporosis treatment: complexities and challenges (Q45028166) (← links)
- Insights into the bisphosphonate holiday: a preliminary FTIRI study (Q46987405) (← links)
- Therapy with pamidronate in children with osteogenesis imperfecta (Q47119385) (← links)
- The Effects of Systemic Therapy of PEGylated NELL-1 on Fracture Healing in Mice (Q47205012) (← links)
- Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk (Q47279165) (← links)
- Local vs. systemic administration of bisphosphonates in rat cleft bone graft: A comparative study (Q47557494) (← links)
- Response to the American College of Physicians Osteoporosis Guideline, 2017 Update (Q47775723) (← links)
- Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. (Q47941432) (← links)
- Treatment of postmenopausal osteoporosis: a literature-based algorithm for use in the public health care system (Q47981699) (← links)
- Bisphosphonate use and the risk of breast cancer: a meta-analysis of observational studies (Q48148231) (← links)
- Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea (Q48210669) (← links)
- Fracture healing: a consensus report from the International Osteoporosis Foundation Fracture Working Group (Q48822821) (← links)
- Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report. (Q49465302) (← links)
- Bisphosphonates in osteoporosis: NICE and easy? (Q49816150) (← links)
- An Essential Warning (Q49895842) (← links)
- Reply to comment on Andrei et al.: The variability of vertebral body volume and pain associated with osteoporotic vertebral fractures: conservative treatment versus percutaneous transpedicular vertebroplasty (Q50126716) (← links)
- Effects of discontinuing oral bisphosphonate treatments for postmenopausal osteoporosis on bone turnover markers and bone density (Q51764274) (← links)